The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2019Measurement of BMP and NAG Activity in CSF Samples
Study Rationale:
Mutations in the LRRK2 gene are a common cause of dominantly inherited Parkinson’s disease (PD). Previous studies showed that urine levels of a lipid [di-22:6-bis(monoacylglycerol... -
Aligning Science Across Parkinson's, 2019Global Parkinson’s Genetics Program (GP2)
GP2 is a resource of the Aligning Science Across Parkinson's (ASAP) Initiative. It is an ambitious five-year program to genotype >150,000 volunteers around the world to further understand the genetic...
-
Research Grant, 2019Developing New 18F-based Brain Tracers for Imaging Synapse in the Human Brain
Study Rationale:
A synapse is a structure that allow nerve cells (neurons) to communicate with one another or with target cells. In the brain, changes in synaptic density are associated with a variety... -
Parkinson's Global Genetics Discovery, 2019Genome-wide Association Study in Parkinson’s Disease Among an East Asian Population
Study Rationale:
The majority of the genome-wide association studies in Parkinson’s disease have included European ancestry cases and controls only, and targeted studies in East Asian populations only... -
Therapeutic Pipeline Program, 2019Clinical Development of AKST4290 as a Novel Parkinson’s Therapeutic
Study Rationale:
There is clear evidence that the immune system plays an important role in the development and progression of Parkinson's disease. Novel therapies targeting the recruitment of immune... -
Research Grant, 2019Restoring the Nigrostriatal Pathway with Living Micto-tissue Engineered Axonal Tracts Supplement
Promising Outcomes of Original Grant:
The classic motor deficits of Parkinson’s disease (PD) are caused by degeneration of dopamine neurons, resulting in the loss of part of the neurons called axonal...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.